The medication rate for ACE inhibitors or ARBs for patients with acute myocardial infarction (AMI) discharged within six months (Disease-specific indicator)
The Health Insurance Administration has selected evidence-based medical indicators to be made public in order to enhance the quality of medical care for patients with myocardial infarction. These indicators will serve as a reference for relevant disease treatment and healthcare quality, with three major categories based on treatment period and quality assessment: inpatient process assessment, assessment of continuous medication after discharge, and outcome assessment. This includes the ratio of inpatients with acute myocardial infarction (AMI) undergoing LDL cholesterol testing during hospitalization, the medication administration ratio for AMI patients during hospitalization and within three, six, and nine months after discharge, the ratio of emergency room visits within three days after discharge for the same primary diagnosis or related condition, and the unplanned readmission ratio within fourteen days after discharge for the same primary diagnosis or related condition.
Data fields
Year、Medical institution code、Name of medical institution、Special contract category、The number of cases receiving ACEI or ARB in the same hospital outpatient clinic within 6 months after discharge from the denominator case.、Discharged AMI case_Exclude Hypotension、The rate of ACE inhibitor or ARB given within 6 months after discharge.、Number of reporting physicians、Average patient age、The number of seriously ill patients、Patient's major illness ratio、County/City Classification、Township differentiation
Contact person
陳綉琴 (02-27065866#3006)
Update frequency
Every June
License
Open Government Data License, version 1.0
Charge
free
Publish date
2015-11-23
Dataset type
System programming interface
Updated time
2025-06-01 10:50
Topic
Other
Service category
Dataset Category
Data archives
Keyword
Medical qualityAcute myocardial infarction.AMIAngiotensin-converting enzyme inhibitorsACEinhibitorAngiotensin II receptor blockersARB
Note
Authorization description URL: https://data.nhi.gov.tw/Banner/DevelopGuide.aspx API documentation for OAS standard: https://data.nhi.gov.tw/openapi.json This dataset resource ID: A21030000I-E32018-001
Related datasets
- The medication rate for ACE inhibitors or ARBs within three months of discharge for patients with acute myocardial infarction (AMI) - (indicator by disease)
- The rate of administration of ACE inhibitors or ARBs to patients with acute myocardial infarction (AMI) during hospitalization (disease-specific indicator)
- The rate of the prescription of angiotensin-converting enzyme inhibitors (ACE inhibitors) or angiotensin II receptor blockers (ARBs) within nine months of discharge for acute myocardial infarction (AMI) patients.
- The rate of medication given within six months after discharge for patients with acute myocardial infarction (AMI) - aspirin (disease-specific indicator)
- Acute myocardial infarction (AMI) patient medication rate during hospitalization - Aspirin (Disease-specific indicator)
Applications
No available applications